862874-75-7 Usage
Uses
Used in Pharmaceutical Industry:
3-(4-AMINO-PHENOXY)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a chemical intermediate for the synthesis of drugs with antibiotic and antiviral properties due to its functional groups that facilitate the development of such therapeutic agents.
Used in Medicinal Chemistry:
As a building block in the synthesis of organic compounds, 3-(4-AMINO-PHENOXY)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is utilized for creating new pharmaceutical compounds, contributing to the advancement of medicinal chemistry and the discovery of novel treatments.
Used in Synthesis Process Protection:
The tert-butyl ester group in 3-(4-AMINO-PHENOXY)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is used to provide stability and protection to the functional groups during the synthesis of pharmaceutical compounds, ensuring the successful production of the desired therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 862874-75-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,2,8,7 and 4 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 862874-75:
(8*8)+(7*6)+(6*2)+(5*8)+(4*7)+(3*4)+(2*7)+(1*5)=217
217 % 10 = 7
So 862874-75-7 is a valid CAS Registry Number.
InChI:InChI=1/C15H22N2O3/c1-15(2,3)20-14(18)17-9-8-13(10-17)19-12-6-4-11(16)5-7-12/h4-7,13H,8-10,16H2,1-3H3
862874-75-7Relevant academic research and scientific papers
BISARYLUREA DERIVATIVES
-
Page/Page column 204-205, (2010/02/13)
The present invention relates to bisarylurea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
DIAMINOTHIAZOLES
-
Page/Page column 25, (2010/02/05)
The present invention is directed to novel diaminothiazoles of formula These compounds inhibit cyclin-dependent kinase 4 (Cdk4) and are selective against Cdk2 and Cdk1. These compounds and their pharmaceutically acceptable salts and esters have antiproliferative activity and are useful in the treatment or control of cancer, in particular solid tumors. This invention is also directed to pharmaceutical compositions containing such compounds and to methods of treating or controlling cancer, most particularly the treatment 6r control of breast, lung and colon and prostate tumors.
